Stem Cell Therapy Cost in India

Stem cell therapy in India has become one of the most sought-after treatment options for international patients looking for advanced regenerative care at significantly lower costs. With globally recognized hospitals, experienced specialists, and modern laboratory infrastructure, India offers a unique combination of affordability, medical expertise, and accessibility.

Patients travel from Nigeria, Kenya, Zambia, Bangladesh, Uzbekistan, the UK, and the USA because India offers the same internationally approved treatments, the same quality of cell processing laboratories, and the same post-treatment care as Western hospitals, at a fraction of the cost.

Stem cell therapy in India typically costs between ₹4 lakh to ₹15 lakh ($5,000–$18,000), depending on the condition, hospital, and type of stem cells used. More complex procedures like stem cell transplants (BMT) can cost between ₹18 lakh to ₹40 lakh ($22,000–$50,000). India offers 60–80% lower costs compared to the US, UK, and Europe, while maintaining high standards of medical care.

In this guide, you’ll find a detailed breakdown of stem cell therapy costs in India, including condition-wise pricing, transplant costs, hospital comparisons, and how to choose the right treatment for your case.

How much does stem cell therapy cost in India in 2026?

Stem cell therapy cost in India ranges from INR 2.5 lakh (approx. USD 3,000) for simple regenerative procedures to INR 35 to 40 lakh (approx. USD 42,000 to USD 48,000) for a full allogeneic bone marrow transplant at a premier JCI-accredited centre. The cost depends on the type of stem cells used, the condition being treated, and whether the treatment is an established transplant or a regenerative therapy. All costs in this guide are quoted in INR first, with USD equivalents.

👉 For a deeper understanding of how regenerative treatments are transforming healthcare in India, explore our detailed guide on regenerative medicine and medical tourism.

Understanding the Two Types of Stem Cell Therapy in India

Before looking at costs, it is essential to understand what you are comparing. This distinction directly affects your expectations, your safety, and your decision.

Important: Some online providers make exaggerated claims about stem cell therapy cures. Any centre that guarantees a cure for neurological or degenerative conditions is not following ICMR or NABH guidelines. Shifam Health works exclusively with ICMR-compliant and JCI or NABH-accredited facilities. We will tell you honestly whether stem cell therapy is an established or investigational option for your specific condition before you travel.

Stem Cell Therapy Cost in India 2026: Complete Breakdown by Condition

The most commonly asked question in your search data is ‘stem cell therapy cost in India in rupees’. Here is the most detailed breakdown available online, organised by condition.

Established Treatments (HSCT / Bone Marrow Transplant)

Regenerative MSC Therapy (Investigational / Clinical Trial Basis)

What is Included in the Stem Cell Therapy Cost in India?

A common source of confusion for international patients is what a quoted cost actually covers. Here is a full itemised breakdown for both BMT and regenerative therapy packages.

Itemized Cost Breakdown (BMT at Premier Private Centre)

What is NOT typically included: Long-term outpatient medications after discharge, donor registry fees for MUD transplants (adds INR 5 to INR 12 lakh), complications requiring extended ICU stay, travel and accommodation costs for patient and family, and physiotherapy or rehabilitation post-discharge. Shifam Health provides a complete written breakdown covering all inclusions and exclusions before you commit.

Stem Cell Therapy Cost by City in India (2026)

The city you choose affects the total cost. Metropolitan hospitals in Delhi, Mumbai, and Bengaluru carry higher overheads but offer the highest volume of complex transplant experience. Emerging medical hubs offer comparable quality at lower cost for many procedures.

Stem Cell Therapy Cost in India vs the World

Here is how India compares to other countries for the same treatments. This is the data international patients from Nigeria, Kenya, the UK, and the USA need before making their decision.

Bone Marrow Transplant Cost Comparison (Allogeneic BMT with Matched Sibling Donor)

What Are the Success Rates for Stem Cell Therapy in India?

Success rates depend entirely on the condition being treated and the type of therapy. Here is an honest breakdown:

Artemis Hospital Gurugram reports 85 to 90 percent success rates for allogeneic transplants in early-stage leukaemia. BLK-Max New Delhi, home to Asia’s largest BMT centre, reports consistently strong outcomes for both malignant and non-malignant conditions. Medanta’s BMT programme, led by Dr. R.K. Chaudhary, is recognised for specialising in haploidentical and MUD transplants with among the best outcomes in the country.

Top Hospitals for Stem Cell Therapy in India: Shifam Health’s Recommended Centres

Shifam Health has direct working knowledge of the following hospitals. We have assessed them based on clinical volume, ICMR compliance, accreditation, international patient experience, and outcomes transparency. We recommend these to our patients because we know what each does well and for which conditions each is best suited.

How Shifam Health Helps International Patients Access Stem Cell Therapy in India

We are not a directory. We are not a referral agency. Shifam Health is a dedicated medical access platform with direct working relationships with India’s leading stem cell therapy centres. Here is what that means for you in practice:

• Honest eligibility assessment: We will tell you upfront whether your condition is suitable for established HSCT or whether you would be accessing investigational MSC therapy. We do not send patients to India for treatments that are not appropriate for their condition.
• Condition-matched centre selection: BLK-Max is not the right centre for everyone. NeuroGen is not right for blood cancer. We know which centres lead for which specific conditions and we match you correctly. This is not something a directory can do.
• Transparent written cost estimate: We provide a detailed INR and USD breakdown for your specific case before you book a flight. No surprises.
• Medical visa coordination: We provide the official hospital invitation letter required for your Indian Medical Visa (MED Visa) and guide you through the documentation process.
  👉 For a step-by-step guide, read our detailed page on the Indian Medical Visa process.
• Travel and accommodation support: Airport pickup, hotel or hospital guesthouse booking, and multilingual coordinator support in Arabic, French, Swahili, Bengali, Russian, and Uzbek.
• In-hospital coordination: We remain actively in contact with the transplant team and the international patient department throughout your stay, attending key consultations where needed.
• Post-treatment follow-up: We connect you with appropriate specialists in your home country for ongoing monitoring and advise on sourcing post-transplant medications from India at significantly lower cost.

Key Factors That Affect Stem Cell Therapy Cost in India

Why does one patient pay INR 8 lakh and another pay INR 35 lakh? Here is a plain explanation of the variables:

• Transplant type: Autologous (own cells) transplants cost significantly less than allogeneic (donor cells) transplants. Haploidentical and MUD transplants are the most complex and expensive due to additional HLA typing, registry fees, and graft-versus-host disease management requirements.
• Disease stage and complexity: Patients with significant complications, organ dysfunction, or previous failed transplants require extended ICU stays and more complex conditioning regimens, increasing total cost.
• Cell dose and number of sessions: Neurological regenerative therapy for conditions like cerebral palsy or spinal cord injury often requires higher cell doses produced through laboratory expansion, which increases processing costs. Some protocols require 2 to 3 sessions.
• Hospital tier and city: JCI-accredited premier centres in Delhi and Mumbai carry higher overheads than mid-tier private hospitals. Cost difference can be 20 to 40 percent for comparable treatments.
• Duration of hospital stay: A standard autologous BMT requires 3 to 4 weeks of hospital stay in a HEPA-filtered room. An allogeneic BMT often requires 4 to 6 weeks. Each additional day in a specialist BMT unit adds INR 8,000 to INR 20,000.
• Complications: Graft-versus-host disease (GVHD) in allogeneic transplants and infections are the main drivers of cost escalation beyond the original estimate. India’s top centres have significantly lower infection rates due to HEPA filtration and dedicated transplant ICU protocols.

Frequently Asked Questions (FAQs)

Conclusion

Stem cell therapy cost in India ranges from INR 2.5 lakh for straightforward regenerative procedures to INR 40 lakh for the most complex allogeneic bone marrow transplants at premier centres. In every case, India offers the same internationally certified treatments, the same GMP laboratory standards, and outcomes that match global benchmarks, at 70 to 90 percent lower cost than the USA or UK.

The key to getting the right result is not just finding the cheapest option. It is matching the right patient to the right treatment at the right centre. That is exactly what Shifam Health does. We give you honest information, a transparent cost estimate, and dedicated personal support throughout your journey.

If you or a family member is considering stem cell therapy in India, reach out today. We will tell you exactly what is possible, what it costs, and how to make it happen safely.

Search

Recent Posts

Stem Cell Therapy Cost in India

Stem Cell Therapy in India: Cost, Success Rate, Best Hospitals (2026 Guide)

Top 10 Cheapest Countries for Spine Surgery

Top 10 Cheapest Countries for Knee Replacement (2026 Cost Comparison Guide)

Quick Inquiry Form

Name

Email

Contact No.

Country

Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Central African Republic Chad Chile China Colombia Comoros Congo (Congo-Brazzaville) Congo (Congo-Kinshasa) Costa Rica Croatia Cuba Cyprus Czechia (Czech Republic) Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini (fmr. "Swaziland") Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, North Korea, South Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar (formerly Burma) Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria North Macedonia (fmr. "Macedonia") Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan Suriname Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City (Holy See) Venezuela Vietnam Yemen Zambia Zimbabwe

Message (Optional)

Send